PACB logo

PACB EBITDA

Annual EBITDA

-$276.92 M
+$365.00 K+0.13%

December 31, 2024

Summary

Performance

1-Year Change

+0.13%

3-Year Change

-10.43%

5-Year Change

-286.89%

15-Year Change

-242.61%

PACB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.62%
PACB annual EBITDA is higher than 4.62% of companies in Healthcare sector

High & Low

All-time High

$38.97 M
PACB annual EBITDA is currently -810.52% below its historical high of $38.97 million

3-Year Low

-$282.24 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
PACB previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
PACB next annual earnings announcement has not yet been scheduled

OtherPACBprofitabilitymetrics:

Annual Revenue

$154.01 M
PACB annual revenue is $154.01 million

Annual Net Income

-$308.65 M
PACB annual net profit is -$308.65 million

Annual EBIT

-$294.92 M
PACB annual earnings before interest & taxes is -$294.92 million

Annual EPS

-$1.58
PACB annual earnings per share is -$1.58

Quarterly EBITDA

$11.27 M
+$52.36 M+127.44%

December 31, 2024

Summary

Performance

3-Month Change

+127.44%

1-Year Change

+127.44%

3-Year Change

+127.44%

5-Year Change

+127.44%

PACB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.86%
PACB quarterly EBITDA is higher than 82.86% of companies in Healthcare sector

High & Low

All-time High

$77.28 M
PACB quarterly EBITDA is currently -85.41% below its historical high of $77.28 million

3-Year Low

-$155.49 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PACB previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
PACB next earnings announcement is scheduled for May 9, 2025

OtherPACBprofitabilitymetrics:

Quarterly Revenue

$39.22 M
PACB quarterly revenue is $39.22 million

Quarterly Net Income

$3.57 M
PACB quarterly net profit is $3.57 million

Quarterly EBIT

$6.64 M
PACB quarterly earnings before interest & taxes is $6.64 million

Quarterly EPS

-$0.49
PACB quarterly earnings per share is -$0.49

TTM EBITDA

-$247.89 M
+$78.74 M+24.11%

December 31, 2024

Summary

Performance

3-Month Change

+24.11%

1-Year Change

+24.11%

3-Year Change

+24.11%

5-Year Change

+24.11%

PACB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.14%
PACB TTM EBITDA is higher than 6.14% of companies in Healthcare sector

High & Low

All-time High

$38.97 M
PACB TTM EBITDA is currently -736.04% below its historical high of $38.97 million

3-Year Low

-$354.07 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
PACB previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
PACB next earnings announcement is scheduled for May 9, 2025

OtherPACBprofitabilitymetrics:

TTM Revenue

$154.01 M
PACB TTM revenue is $154.01 million

TTM Net Income

-$308.65 M
PACB TTM net profit is -$308.65 million

TTM EBIT

-$294.92 M
PACB TTM earnings before interest & taxes is -$294.92 million

TTM EPS

-$1.64
PACB TTM earnings per share is -$1.64

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$276.92 M
PACB annual EBITDA is -$276.92 million

Annual Net Income

-$308.65 M
PACB annual net profit is -$308.65 million

Annual Interest Expense

$13.41 M
PACB annual interest expense is $13.41 million

Annual Income Tax

$316.00 K
PACB annual income tax is $316.00 thousand

Annual D&A

-
PACB annual depreciation & amortization value is unknown

PACB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.1%+127.4%+24.1%
3 y3 years-10.4%+127.4%+24.1%
5 y5 years-286.9%+127.4%+24.1%

PACB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.4%+1.9%at high+107.3%-2.8%+30.0%
5 y5-year-810.5%+1.9%-85.4%+107.3%-736.0%+30.0%
alltimeall time-810.5%+1.9%-85.4%+107.3%-736.0%+30.0%

Pacific Biosciences Of California EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$276.92 M(-0.1%)
$11.27 M(-127.4%)
-$247.89 M(-24.1%)
Sep 2024
-
-$41.09 M(-73.6%)
-$326.63 M(-7.8%)
Jun 2024
-
-$155.49 M(+148.4%)
-$354.07 M(+36.2%)
Mar 2024
-
-$62.59 M(-7.2%)
-$260.00 M(-6.2%)
Dec 2023
-$277.28 M(-1.8%)
-$67.47 M(-1.6%)
-$277.28 M(-3.1%)
Sep 2023
-
-$68.53 M(+11.6%)
-$286.01 M(-0.2%)
Jun 2023
-
-$61.41 M(-23.1%)
-$286.47 M(-0.8%)
Mar 2023
-
-$79.87 M(+4.8%)
-$288.65 M(+2.2%)
Dec 2022
-$282.24 M(+12.6%)
-$76.19 M(+10.4%)
-$282.55 M(+6.0%)
Sep 2022
-
-$68.99 M(+8.5%)
-$266.57 M(-1.1%)
Jun 2022
-
-$63.60 M(-13.8%)
-$269.62 M(+11.9%)
Mar 2022
-
-$73.76 M(+22.5%)
-$241.04 M(-3.8%)
Dec 2021
-$250.76 M(-743.4%)
-$60.21 M(-16.4%)
-$250.60 M(+121.6%)
Sep 2021
-
-$72.05 M(+105.7%)
-$113.11 M(+81.1%)
Jun 2021
-
-$35.02 M(-58.0%)
-$62.45 M(+29.4%)
Mar 2021
-
-$83.32 M(-207.8%)
-$48.24 M(-223.8%)
Dec 2020
$38.97 M(-154.5%)
$77.28 M(-461.3%)
$38.97 M(-210.7%)
Sep 2020
-
-$21.39 M(+2.8%)
-$35.21 M(-11.3%)
Jun 2020
-
-$20.81 M(-634.4%)
-$39.72 M(-1.8%)
Mar 2020
-
$3.90 M(+25.7%)
-$40.43 M(-43.5%)
Dec 2019
-$71.58 M(-23.0%)
$3.10 M(-112.0%)
-$71.58 M(-30.6%)
Sep 2019
-
-$25.90 M(+20.3%)
-$103.06 M(+3.3%)
Jun 2019
-
-$21.53 M(-21.0%)
-$99.77 M(+1.4%)
Mar 2019
-
-$27.25 M(-4.0%)
-$98.38 M(+5.9%)
Dec 2018
-$92.92 M(+15.0%)
-$28.39 M(+25.6%)
-$92.92 M(+12.1%)
Sep 2018
-
-$22.60 M(+12.3%)
-$82.86 M(+3.8%)
Jun 2018
-
-$20.13 M(-7.6%)
-$79.85 M(-3.1%)
Mar 2018
-
-$21.80 M(+18.9%)
-$82.44 M(+2.0%)
Dec 2017
-$80.83 M(+20.2%)
-$18.33 M(-6.5%)
-$80.83 M(+1.5%)
Sep 2017
-
-$19.59 M(-13.8%)
-$79.64 M(+5.2%)
Jun 2017
-
-$22.72 M(+12.6%)
-$75.72 M(+8.6%)
Mar 2017
-
-$20.18 M(+17.7%)
-$69.72 M(+3.6%)
DateAnnualQuarterlyTTM
Dec 2016
-$67.27 M(+168.1%)
-$17.14 M(+9.3%)
-$67.27 M(+35.1%)
Sep 2016
-
-$15.67 M(-6.3%)
-$49.78 M(+62.2%)
Jun 2016
-
-$16.73 M(-5.6%)
-$30.70 M(+26.6%)
Mar 2016
-
-$17.73 M(-5208.1%)
-$24.25 M(-3.4%)
Dec 2015
-$25.09 M(-57.5%)
$347.00 K(-89.8%)
-$25.09 M(-41.3%)
Sep 2015
-
$3.41 M(-133.2%)
-$42.78 M(-20.2%)
Jun 2015
-
-$10.28 M(-44.6%)
-$53.64 M(-11.6%)
Mar 2015
-
-$18.57 M(+7.1%)
-$60.70 M(+2.7%)
Dec 2014
-$59.11 M(-16.9%)
-$17.34 M(+132.8%)
-$59.11 M(+3.9%)
Sep 2014
-
-$7.45 M(-57.1%)
-$56.90 M(-16.2%)
Jun 2014
-
-$17.34 M(+2.2%)
-$67.91 M(-1.5%)
Mar 2014
-
-$16.98 M(+12.2%)
-$68.96 M(-3.1%)
Dec 2013
-$71.17 M(-18.7%)
-$15.13 M(-18.0%)
-$71.17 M(-6.4%)
Sep 2013
-
-$18.46 M(+0.4%)
-$76.03 M(-3.2%)
Jun 2013
-
-$18.39 M(-4.1%)
-$78.55 M(-2.8%)
Mar 2013
-
-$19.18 M(-4.0%)
-$80.85 M(-7.6%)
Dec 2012
-$87.54 M(-15.3%)
-$19.99 M(-4.7%)
-$87.54 M(-0.6%)
Sep 2012
-
-$20.97 M(+1.3%)
-$88.08 M(-7.4%)
Jun 2012
-
-$20.69 M(-20.0%)
-$95.10 M(-0.6%)
Mar 2012
-
-$25.88 M(+26.1%)
-$95.68 M(-7.4%)
Dec 2011
-$103.30 M(-23.5%)
-$20.53 M(-26.7%)
-$103.30 M(-12.4%)
Sep 2011
-
-$28.00 M(+31.6%)
-$117.90 M(-8.7%)
Jun 2011
-
-$21.28 M(-36.5%)
-$129.16 M(-7.3%)
Mar 2011
-
-$33.50 M(-4.6%)
-$139.35 M(+3.2%)
Dec 2010
-$135.07 M(+60.9%)
-$35.13 M(-10.5%)
-$135.07 M(+7.1%)
Sep 2010
-
-$39.25 M(+24.7%)
-$126.17 M(+13.5%)
Jun 2010
-
-$31.47 M(+7.7%)
-$111.15 M(+39.5%)
Mar 2010
-
-$29.22 M(+11.4%)
-$79.68 M(+57.9%)
Dec 2009
-$83.97 M(+100.8%)
-$26.23 M(+8.2%)
-$50.46 M(+108.2%)
Sep 2009
-
-$24.24 M
-$24.24 M
Dec 2008
-$41.82 M(+91.7%)
-
-
Dec 2007
-$21.81 M
-
-

FAQ

  • What is Pacific Biosciences of California annual EBITDA?
  • What is the all time high annual EBITDA for Pacific Biosciences of California?
  • What is Pacific Biosciences of California annual EBITDA year-on-year change?
  • What is Pacific Biosciences of California quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Pacific Biosciences of California?
  • What is Pacific Biosciences of California quarterly EBITDA year-on-year change?
  • What is Pacific Biosciences of California TTM EBITDA?
  • What is the all time high TTM EBITDA for Pacific Biosciences of California?
  • What is Pacific Biosciences of California TTM EBITDA year-on-year change?

What is Pacific Biosciences of California annual EBITDA?

The current annual EBITDA of PACB is -$276.92 M

What is the all time high annual EBITDA for Pacific Biosciences of California?

Pacific Biosciences of California all-time high annual EBITDA is $38.97 M

What is Pacific Biosciences of California annual EBITDA year-on-year change?

Over the past year, PACB annual EBITDA has changed by +$365.00 K (+0.13%)

What is Pacific Biosciences of California quarterly EBITDA?

The current quarterly EBITDA of PACB is $11.27 M

What is the all time high quarterly EBITDA for Pacific Biosciences of California?

Pacific Biosciences of California all-time high quarterly EBITDA is $77.28 M

What is Pacific Biosciences of California quarterly EBITDA year-on-year change?

Over the past year, PACB quarterly EBITDA has changed by +$52.36 M (+127.44%)

What is Pacific Biosciences of California TTM EBITDA?

The current TTM EBITDA of PACB is -$247.89 M

What is the all time high TTM EBITDA for Pacific Biosciences of California?

Pacific Biosciences of California all-time high TTM EBITDA is $38.97 M

What is Pacific Biosciences of California TTM EBITDA year-on-year change?

Over the past year, PACB TTM EBITDA has changed by +$78.74 M (+24.11%)